Organization: Crucell NV

AstraZeneca buys DSM’s Montreal facility

AstraZeneca has acquired the mothballed Montreal biologics manufacturing facility from DSM Biologics Inc — the second major investment the UK-based pharmaceutical firm has made in Montreal this year. AstraZeneca will begin re-commissioning the facility immediately and expects to begin full-scale production in 2009. Located adjacent to the National Research Council‘s Biotechnology Research Institute, it will…